SCNI

Scinai Immunotherapeutics
$0.25
+$0.02 (+7.39%)Jul 27, 2026

Key metrics

The numbers that frame SCNI today
Market cap
$0.00
Div yield
0%
Debt / equity
0.3
52wk Low
$0.22
52wk High
$3.48

SCNI stock rating

How SCNI scores on quality, value, growth, momentum and financial health
n/aout of 10
No overall ratingNeutral business, valuation unclear
QualityNo scoren/a/10
GrowthNo scoren/a/10
MomentumPoor0.2/10
ValueNo scoren/a/10
Financial HealthNo scoren/a/10

Growth

Revenue and earnings trend for SCNI
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about SCNI
Is Scinai Immunotherapeutics a good buy?
No. Scinai Immunotherapeutics has poor momentum.
What is the market capitalization of SCNI?
Scinai Immunotherapeutics's market capitalization is $0.00.
What is the 52-week high for SCNI stock?
The 52-week high for Scinai Immunotherapeutics is $3.48. The current close of $0.25 is 92.9% below that high.
What is the 52-week low for SCNI stock?
The 52-week low for Scinai Immunotherapeutics is $0.22. The current close of $0.25 is 14.9% above that low.
Does SCNI stock pay dividends?
Scinai Immunotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SCNI?
Scinai Immunotherapeutics's Debt / Equity ratio is 0.3.